Chemotherapy has been shown to increase PD-L1 expression on TCs (59, 60), in addition to possibly reducing the quantity and activity of suppressive ICs, inducing immunogenic cell death, activating and maturing dendritic cells, enhancing tumor antigen presentation, and increasing effector T-cell function (61). Here, CD274 is linked to neoplasm.